drugset / Trial / NCT00273299
Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the potential of using valsartan/HCTZ as initial therapy in patients with severe hypertension compared to valsartan alone as initial therapy, and to determine whether a greater proportion of patients achieve blood pressure control with the combination compared to the monotherapy without producing an unacceptable adverse event profile.
Timeline
- Start
- 2005-11
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 25 mg | — |
| Subject | Valsartan | Small molecule | 320 mg | — |